Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Published on by sciencefatherLeave a Comment on Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Prof. Dr. Esmail El-Fakharany | Drug Delivery | Research Excellence Award

City of Scientific Research and Technological Applications | Egypt

Prof. Dr. Esmail El-Fakharany is a distinguished scientist affiliated with the Protein Research Department at the Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, where his work significantly advances biomedical and biotechnological research. He earned his Ph.D. in Microbiology with a minor specialization in biotechnology in 2012, following an M.Sc. in Microbiology with a focus on antiviral agents in 2009, both from the Faculty of Science, Al-Azhar University, Cairo. His academic foundation is further strengthened by a Diploma in Public Health Microbiology from the High Institute of Public Health, Alexandria University, and a B.Sc. in Microbiology with excellent distinction. Prof. Dr. El-Fakharany possesses extensive experience in immunology and immunoblotting, molecular biology, therapeutic protein and enzyme purification, antiviral and anticancer agent investigation, microbiological techniques, and tissue culture and cell line maintenance. His primary research interests center on antiviral proteins, recombinant and natural bioactive molecules, therapeutic protein engineering, immunological applications, and biotechnology-driven drug development. Through sustained scientific contributions, he has received professional recognition for excellence in microbiology and biotechnology research. Overall, his work continues to play a vital role in translating fundamental microbiological insights into innovative therapeutic strategies, contributing meaningfully to global health and applied life sciences.

View Google Scholar Profile

Featured Publications

Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study

Virology Journal, 2013, Vol. 10(1), Article 199

Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells

Protein & Peptide Letters, 2010, Vol. 17(8), pp. 1031–1039

Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and HeLa cell lines

Hepatitis Monthly, 2011, Vol. 11(9)

Potential lactoferrin activity against pathogenic viruses

Comptes Rendus Biologies, 2014, Vol. 337(10), pp. 581–595

Poly(vinyl alcohol)–hyaluronic acid membranes for wound dressing applications: synthesis and in vitro bio-evaluations

Journal of the Brazilian Chemical Society, 2015, Vol. 26(7), pp. 1466–1474

Radwa Mahmoud | Biotechnology | Excellence in Research Award

Published on by sciencefatherLeave a Comment on Radwa Mahmoud | Biotechnology | Excellence in Research Award

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Published on by sciencefather

Ms. Yufang Ma-Pharmaceutical Chemistry-Best Researcher Award

Wuhan University - China

Author Profile

Early Academic Pursuits

Ms. Yufang Ma's academic journey began with a fervent interest in the biomedical sciences. She completed her undergraduate studies with a focus on pharmacology, where she developed a strong foundation in understanding drug interactions and biological systems. Her early research interests centered around natural compounds, particularly flavonoids, which are known for their diverse pharmacological properties. This interest led her to delve deeper into the conformational relationships of these compounds, exploring how their structures influence their biological activities. Her dedication to her studies was reflected in her academic excellence and active participation in various research initiatives.

Professional Endeavors

Following her undergraduate studies, Ms. Yufang Ma pursued a Master's degree at Wuhan University, one of the top institutions in China. Her professional endeavors have been marked by her commitment to advancing pharmacological research. At Wuhan University, she has been primarily engaged in studying the conformational relationships of flavonoids and their pharmacological effects. Her research aims to uncover the therapeutic potential of these natural compounds, particularly in the context of treating neurological disorders such as epilepsy. This work not only contributes to the scientific community's understanding of flavonoids but also has the potential to lead to the development of new, effective treatments for epilepsy.

Contributions and Research Focus

Ms. Yufang Ma's contributions to pharmacological research are centered on her in-depth studies of flavonoids. Her primary research focus involves investigating the conformational relationships of these compounds and how their structural variations impact their pharmacological properties. She is particularly interested in the therapeutic potential of flavonoids in treating epilepsy, a neurological disorder characterized by recurrent seizures. Through her research, she aims to identify specific flavonoids that can modulate neuronal activity and reduce seizure frequency. This focus on epilepsy research is a significant contribution to the field, as it addresses a critical need for new, effective treatments for this debilitating condition.

Accolades and Recognition

While Yufang Ma's work is ongoing, she has already garnered recognition for her contributions to pharmacological research. Her dedication to exploring the therapeutic potential of flavonoids has been acknowledged by her peers and mentors at Wuhan University. Although she has not yet published extensively or secured patents, her research on epilepsy is paving the way for significant advancements in the field. The recognition she has received serves as a testament to her potential to make impactful contributions to pharmacology and therapeutics.

Impact and Influence

The impact of Yufang Ma's research extends beyond the academic community. Her work on flavonoids and epilepsy has the potential to influence the development of new pharmacological treatments. By identifying specific flavonoids with anticonvulsant properties, her research could lead to the creation of novel therapies that offer better efficacy and fewer side effects compared to existing treatments. This potential impact highlights the broader significance of her work in improving patient outcomes and enhancing the quality of life for individuals with epilepsy.

Legacy and Future Contributions

Ms. Yufang Ma's legacy in pharmacological research is still in the making, but her ongoing work promises to leave a lasting impact on the field. As she continues to explore the therapeutic potential of flavonoids, her findings could pave the way for new treatment paradigms in epilepsy and other neurological disorders. Her future contributions are likely to extend beyond research, potentially influencing clinical practices and drug development strategies. With her dedication and innovative approach, Ms. Yufang Ma is poised to become a leading figure in pharmacology, contributing to the advancement of science and the improvement of human health.

Notable Publication

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity, 2024.

Diosmetin Ameliorates HFD-induced Cognitive Impairments via Inhibiting Metabolic Disorders, Mitochondrial Dysfunction and Neuroinflammation in Male SD Rats, 2024